Do PHI and PHI density improve detection of clinically significant prostate cancer only in the PSA gray zone?

MLA

Rius Bilbao, Leire, et al. “Do PHI and PHI Density Improve Detection of Clinically Significant Prostate Cancer Only in the PSA Gray Zone?” Clinica Chimica Acta; International Journal of Clinical Chemistry, vol. 542, Mar. 2023, p. 117270. EBSCOhost, https://doi.org/10.1016/j.cca.2023.117270.

APA

Rius Bilbao, L., Valladares Gomez, C., Aguirre Larracoechea, U., Pereira Arias, J. G., Arredondo Calvo, P., Urdaneta Salegui, L. F., Escobal Tamayo, V., Sanz Jaka, J. P., Recio Ayesa, A., Mar Medina, J., & Mar Medina, C. (2023). Do PHI and PHI density improve detection of clinically significant prostate cancer only in the PSA gray zone? Clinica Chimica Acta; International Journal of Clinical Chemistry, 542, 117270. https://doi.org/10.1016/j.cca.2023.117270

Chicago

Rius Bilbao, Leire, Carmen Valladares Gomez, Urko Aguirre Larracoechea, Jose Gregorio Pereira Arias, Pablo Arredondo Calvo, Luis Felipe Urdaneta Salegui, Victor Escobal Tamayo, et al. 2023. “Do PHI and PHI Density Improve Detection of Clinically Significant Prostate Cancer Only in the PSA Gray Zone?” Clinica Chimica Acta; International Journal of Clinical Chemistry 542 (March): 117270. doi:10.1016/j.cca.2023.117270.